OnKure Therapeutics (NASDAQ:OKUR - Get Free Report)'s stock had its "buy" rating reaffirmed by HC Wainwright in a research report issued on Thursday, Benzinga reports. They currently have a $40.00 price objective on the stock. HC Wainwright's price objective suggests a potential upside of 122.84% from the company's current price.
OKUR has been the subject of several other research reports. Oppenheimer initiated coverage on OnKure Therapeutics in a research report on Thursday, October 10th. They issued an "outperform" rating and a $35.00 price objective for the company. Lifesci Capital upgraded OnKure Therapeutics to a "strong-buy" rating in a research note on Thursday, October 10th.
Read Our Latest Stock Analysis on OKUR
OnKure Therapeutics Trading Down 3.4 %
Shares of NASDAQ OKUR traded down $0.64 during mid-day trading on Thursday, hitting $17.95. 70,670 shares of the stock were exchanged, compared to its average volume of 27,506. OnKure Therapeutics has a twelve month low of $9.80 and a twelve month high of $86.70. The firm has a market cap of $59.95 million, a price-to-earnings ratio of -1.07 and a beta of 0.21.
OnKure Therapeutics Company Profile
(
Get Free Report)
Reneo Pharmaceuticals Incis a clinical stage pharmaceutical company. It is focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases. Reneo Pharmaceuticals Incis based in SAN DIEGO.
Featured Articles
Before you consider OnKure Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and OnKure Therapeutics wasn't on the list.
While OnKure Therapeutics currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
